51 – 60 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
(
- Contribution to journal › Article
-
Mark
Disclosure of payments by pharmaceutical companies to healthcare professionals in the United Kingdom: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
(
- Contribution to journal › Article
-
Mark
Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny
(
- Contribution to journal › Letter
-
Mark
Overuse of methylphenidate : an analysis of Swedish pharmacy dispensing data
(
- Contribution to journal › Article
-
Mark
Chronic Obstructive Pulmonary Disease in Sweden: an intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy
(
- Contribution to journal › Article
-
Mark
Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden
(
- Contribution to journal › Article
-
Mark
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
(
- Contribution to journal › Article
- 2017
-
Mark
Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches
(
- Contribution to journal › Article
-
Mark
Intersektionalitet och risk för ischemisk hjärtsjukdom i Sverige
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
An intersectional approach to multilevel analysis of individual heterogeneity (MAIH) and discriminatory accuracy
(
- Contribution to journal › Article